Case Assignment for Opt-e-Scrip Essay Example | Topics and Well Written Essays - 1250 words

Case Assignment for Opt-e-Scrip - Essay Example1) pharmaceutical companies they want do drugss to be rolled out in market with a big bang. They want large marketing campaigns to surround the drug in order for it to be profitable. Nothing wrong in it, just with serious doubts on drug efficacy and serious issue of low drug response view ass the prices of mark drugs unjustified. Companies will want to see this product sidelined as this poses a serious threat to their job plans. 2) Wholesalers they atomic number 18 not so concerned with OES products and not directly bear on. But if our products go global and piss a tolerant spread impact even the wholesalers will be touch as majority of its business comes from selling high priced branded drugs. 3) Pharmacy Benefit Managers (PBM) they atomic number 18 the ones who will be certainly affected by OES products. They are the ones who list down the products under the benefit plan and hence the pharma co. gets business. They excessi vely get commission and under the table benefits in cash and kind for including costly branded drugs. PBM efficacy not want our drug to go global. Only 4 PBMs control more than 50% of drug market which means they live an immense power over the drug industry, its prices and policies. 4) Retail pharmacies their involvement in the whole drug distribution market was important but the effect of OES will not be as intense. They sell generic and branded products and rely upon their margins and some incentives of selling branded drugs. If they are not able to sell a lot of branded products, they can diversify and sell many some other related products. Only the large retails pharmacy chains which are also PBMs might be affected by PMT. 5) Health insurance carriers many are a part of PBM or outsourced to them and few have their own PBM service in-house. They work in very close coordination with PBMs. It is good for health insurance companies to actually see OES products do well so that it saves on the payouts to people who claim benefit from them. If we try to set about their support for OES and keep them as confederates it will help us. 6) Employers one leads to another, a cascading effect where employers and payers can lick a big role. Employer can use health insurers who use such PBMs who support our products and hence create a win win for overall benefit of society. 7) Physicians they are one of the key. Though the plan skirt them failed once, OES should not be let down by it. There is scope to win their support and make OES products a hit. 8) Consumers they are the one who are the key beneficiaries of the whole OES campaign to introduce PMT. If a wide spread public support is seeked it will help OES reinforce the concept for the drug industry. Analysis of constancy The industry is more complex than it appears. You are the best person to realize this fact and know counterbalance hand how tough it was to introduce this revolutionary product in drug market. A s shown in the appendage The pharmaceutical drug market, physical drug distribution and benefit distribution are two link channels which operate in the country. OES should consciously target the benefit distribution because that is where the key critical decisions are taken which impacts the cost of drug delivery to the end user. This is where the decision of inclusion and non inclusion of branded procure drugs vs. generic drug is taken. Pharmaceutical industries are using three distinct strategies to